BRM
COV

Boston Research & Management’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Boston Research & Management’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-26,266
Closed -$1.93M – 101
2014
Q1 		$1.93M Sell
26,266
-217
-0.8% -$15.1K 1.42% 34
2013
Q4 		$1.8M Sell
26,483
-359
-1% -$23.4K 1.39% 40
2013
Q3 		$1.64M Sell
26,842
-2,775
-9% -$169K 1.38% 40
2013
Q2 		$1.65M Buy
+29,617
New +$1.71M 1.47% 32

Other funds holding COV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Boston Research & Management's COV Position: Q2 2014 in Review

Boston Research & Management sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q2 2014, closing a stake of 26,266 shares — an estimated $1.93M sold.

Boston Research & Management first reported a position in COV in Q2 2013 and held it in 4 quarters. The position peaked at $1.93M in Q1 2014. 804 funds tracked by Wall St. Rank hold COV as of Q2 2014.

  • Boston Research & Management reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q2 2014 after selling out during the quarter.
  • Boston Research & Management sold 26,266 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q2 2014, an estimated $1.93M.
  • Boston Research & Management first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 4 quarters.
  • Boston Research & Management's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.93M in Q1 2014.
  • 804 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q2 2014.

Based on Boston Research & Management's 13F filing for Q2 2014, filed 12 Aug 2014.